SARS STOCKS

[Rocketred]

VIRAGEN INC (VRA)March 20, 2003 ALPHA NATURAL INTERFERON


We are a biotechnology company engaged in the business of researching, developing and manufacturing innovative technologies for the treatment of life-threatening illnesses. We are also in the business of developing innovative technologies aimed at improving the manufacturing processes used to manufacture certain medical therapies. Specifically, we are primarily focused on three fields of research and development:


• human leukocyte derived interferon -- natural alpha interferon derived
from human white blood cells for the treatment of a wide range of viral
and malignant diseases.

• avian transgenics technologies designed to produce protein-based drugs
inside the egg whites of transgenic developed chickens.

• oncological therapies -- therapeutic proteins for the treatment of
targeted cancers.


We are a biotechnology company engaged in the business of researching, developing and manufacturing innovative technologies for the treatment of life-threatening illnesses. We are also in the business of developing innovative technologies aimed at improving the manufacturing processes used to manufacture certain medical therapies. Specifically, we are primarily focused on three fields of research and development:


• human leukocyte derived interferon -- natural alpha interferon derived
from human white blood cells for the treatment of a wide range of viral
and malignant diseases.

• avian transgenics technologies designed to produce protein-based drugs
inside the egg whites of transgenic developed chickens.

• oncological therapies -- therapeutic proteins for the treatment of
targeted cancers.